Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Biden's Executive Order to lower copays for some drugs to $2 for Medicare and Medicaid enrollees is nixed by President Trump.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs. The cap will reduce out-of-pocket spending for potentially millions of older ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.

For those with prescription drug costs, this can be particularly burdensome. Fortunately, Medicare's prescription drug law includes a provision to spread these costs throughout the year, making ...

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden ...